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PURPOSE: To determine the incidence and characteristics of nonimmune hydrops fetalis in the newborn population.
METHOD: A retrospective study of the period between 1996 and 2000, including all newborns with a prenatal or early
neonatal diagnosis of nonimmune hydrops fetalis, based on clinical history, physical examination, and laboratory evaluation.
The following were analyzed: prenatal follow-up, delivery type, gender, birth weight, gestational age, presence of perinatal
asphyxia, nutritional classification, etiopathic diagnosis, length of hospital stay, mortality, and age at death.
RESULTS: A total of 47 newborns with hydrops fetalis (0.42% of live births), 18 (38.3%) with the immune form and 29
(61.7%) with the nonimmune form, were selected for study. The incidence of nonimmune hydrops fetalis was 1 per 414
neonates. Data was obtained from 21 newborns, with the following characteristics: 19 (90.5%) were suspected from prenatal
diagnosis, 18 (85.7%) were born by cesarean delivery, 15 (71.4%) were female, and 10 (47.6%) were asphyxiated. The
average weight was 2665.9 g, and the average gestational age was 35 3/7 weeks; 14 (66.6%) were preterm; 18 (85.0 %)
appropriate delivery time; and 3 (14.3%) were large for gestational age. The etiopathic diagnosis was determined for 62%,
which included cardiovascular (19.0%), infectious (9.5%), placental (4.8%), hematologic (4.7%), genitourinary (4.8%), and
tumoral causes (4.8%), and there was a combination of causes in 9.5%. The etiology was classified as idiopathic in 38%. The
length of hospital stay was 26.6 ± 23.6 days, and the mortality rate was 52.4%.
CONCLUSIONS: The establishment of a suitable etiopathic diagnosis associated with prenatal detection of nonimmune
hydrops fetalis can be an important step in reducing the neonatal mortality rate from this condition.
DESCRIPTORS: Hydrops fetalis. Nonimmune hydrops fetalis. Newborn infant. Anasarca. Hydropic.
Hydrops fetalis is defined as the ex-
cessive accumulation of fluids in the
interstitial compartment1 including
edema, ascites, and pleural and pericar-
dial effusions2, leading to anasarca.
One of the methods used to clas-
sify hydrops fetalis is to categorize it
according to immune and nonimmune
causes3, because nowadays, as a con-
sequence of a more precocious detec-
tion and a higher control of the im-
mune causes, 75% of the perinatal
cases are of nonimmune etiology4. The
main pathophysiologic mechanism in-
volved in the genesis of nonimmune
hydrops fetalis (NHF) is related to ab-
normal fluid transportation between
plasma and tissues. In this pathologi-
cal situation, the primary causes of
modification of the distribution of
body fluids are the increase of hydro-
static capillary pressure and capillary
permeability and reduction of plasma
osmotic pressure or lymphatic flow2,4,5.
Regarding etiology, NHF is differ-
ently classified in the literature, with-
out consensus3,4,6,7. We have developed
a classification system, presented on
table 1, in which the main causes are
classified as cardiovascular, genetic,
infectious, placental, hematologic,
miscellaneous and/or multiple causes,
and idiopathic.
Foremost among the main causes
of NHF are the cardiovascular, genetic,
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Table 1 - Causes of nonimmune hydrops fetalis.
CARDIOVASCULAR
• Arrhythmia
• Myocardiopathy
• Structural malformations (Ebstein anomaly, premature closure of the foramen ovale)
• Vascular obstruction (tumor, structural, fibroelastosis)
• Vascular malformation and hemangioma
GENETIC
• Skeletal dysplasias and myopathies
• Metabolic diseases (Gaucher, GM1 gangliosidosis, mucopolysaccharidosis)
• Autosomic diseases (Nooan, Prune belly, Fanconi)
• Chromosomal abnormalities (trisomy 21, 18, 13, Turner’s syndrome)
CONGENITAL INFECTIONS
• Virus (cytomegalovirus, parvovirus B19, rubella, varicella, herpes, sintitial respiratory)
• Toxoplasmosis
• Syphilis
• Chagas disease
HEMATOLOGIC
• Nonimmune anemia
• Alpha-thalassemia
• Others (leukemia)
PLACENTAL
• Twin-twin transfusion syndrome
• Causes related to the umbilical cord
MISCELLANEOUS
• Respiratory (pulmonary sequestration, adenomatoid disease, chylothorax, tumor)
• Genitourinary (obstructive uropathy, dysplasia, cysts, thrombosis, nephrotic syndrome)
• Gastrointestinal (duodenal/jejunal atresia, anal imperforation, peritonitis)
• Neurological (encephalocele, intracranial hemorrhage, cerebral aneurysm)
• Tumoral (sacrococcygeal teratoma, neuroblastoma, hepatoblastoma)
• Multiple causes (presence of more than one associated etiopathic causes)
IDIOPATHIC
• Non-defined cause
Modified from the classification of Phibbs R, 1996.2
infectious, placental, and hematologic
causes, among others (Table 1). De-
spite the technological advances in
the last decades, the cause in 50% of
the cases remains undefined, which are
classified as idiopathic2.
The occurrence of NHF is not fre-
quent, occurring in 1 of 3000 live
births2,8,9. Moreover, a high mortality
rate is associated with NHF; 50% of the
cases diagnosed in the intrauterine pe-
riod evolve to death, and 50% of the
live newborns who have the disease do
not survive the neonatal period2.
As previously mentioned, the prog-
nosis of the newborn with NHF de-
pends directly on an etiopathic diag-
nosis and on the prevention of prema-
turity10. In order to have an effective
reduction in morbidity and mortality
rates, a correct and precocious etio-
pathic diagnosis becomes fundamen-
tal, so that an adequate perinatal ap-
proach is possible.
This study aims at determining the
incidence and characterization of NHF
in newborns admitted to a neonatal
risk unit during a 5-year period.
PATIENTS  AND  METHODS
A retrospective study was per-
formed from January 1996 to Decem-
ber 2000.
Every newborn that was born dur-
ing this period and had an immediate
prenatal or neonatal diagnosis of hy-
drops was included in the study. Hy-
drops was characterized by 1 or more
clinical signs, such as anasarca, periph-
eral edema, ascites, pericardial and/or
pleural effusions, anemia, congestive
heart failure, and hypoalbuminemia.
From these newborns, the ones with
an immune etiology were excluded,
based on clinical history, laboratory
evaluation (blood type and Coombs
tests of the newborn and the mother),
and clinical evolution.
The presence of the clinical pres-
entation and the absence of maternal-
fetal blood incompatibility defined
NHF.
Among the newborns that fulfilled
the inclusion criteria, the following fac-
tors were evaluated: occurrence of pre-
natal diagnosis of hydrops, gender, type
of delivery, gestational age, birth
weight, nutritional adequacy of birth
weight, presence of perinatal asphyxia,
etiopathic diagnosis, mortality, age at
death, and length of hospital stay.
The gestational age (GA) was
based on the last menstruation date and
ultrasonographic and postnatal classi-
fication methods (Capurro11,
Dubowitz12, or New Ballard Score13).
The newborns with a GA greater than
or equal to 37 weeks were considered
term. For the calculation of the defini-
tive GA, the following criteria were
used in descending order of priority,
according to the service routine:
- maternal information about the
date of the last menstrual period
(Naegele’s rule, that considers 280
days as the normal gestation time)
when this date differs less than 2
weeks from the early fetal ultra-
sonography;
- early ultrasonography performed
during the first 20 weeks of gesta-
tion, in cases when the GA was not
considered reliable and the differ-
ence among the calculated ages by
the ultrasonography and postnatal
methods was less than 2 weeks;
- calculated postnatal age through
the Capurro, Dubowitz, or New
Ballard Score methods, when this
age differs more than 2 weeks from
both the ultrasonographic and GA
as determined from maternal infor-
mation.
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Table 2 - Characterization and etiopathic diagnosis of the study population.
Cause Delivery Gender Birth Apgar Gesta- Weeks Classification Evolution Diagnosis
weight tional
(g) age
Cardiovascular cesarean female 1970 2/6/8 33 5/7 preterm,  AGA discharge - 39 days Myocardiopathy *
cesarean female 3150 4/7/9 37 4/7 term,  AGA death - 6 days Supra-ventricular
tachyarrhythmia *
cesarean male 3600 2/6/6 38 term,  AGA discharge - 81 days Ebstein + hydronephrosis *
cesarean female 2680 1/6/7 32 1/7 preterm, LGA transferred Aortic and pulmonary
stenosis *
Genetic cesarean female 2460 0/0/2 34 3/7 preterm, AGA death - 3 days GM1 Gangliosidosis type 1 *
cesarean female 3460 2/2/1 33 3/7 preterm, LGA death - 1 hour Thanatophoric dysplasia *
Infectious cesarean male 2840 3/9/10 38 1/7 term,  AGA discharge - 18 days Congenital rubella *
cesarean male 2670 8/9/9 36 3/7 preterm, AGA discharge - 29 days Toxoplasmosis *
Hematologic forceps female 2420 8/9/9 37 4/7 term,  AGA discharge - 7 days Non hemolytic anemia*
Placental cesarean male 2850 8/9/9 35 3/7 preterm, AGA discharge - 11 days Twin-twin transfusion
syndrome *
Miscellaneous cesarean female 1660 3/7/7 33 preterm, AGA death - 12 days Congenital nephrotic
and/or syndrome  + trissomy 21 *
Multiple causes vaginal female 2530 3/5/5 34 6/7 preterm, AGA discharge  - 44 days Ebstein + trissomy 21 *
cesarean female 3470 1/1/1 39 3/7 term,  AGA death - 6 hours Thoracic-abdominal tumors +
pulmonary hypoplasia*
Idiopathic cesarean female 2015 1/5/7 37  3/7 term,  AGA death - 19 hours Idiopathic *
vaginal male 2680 1/7/8 35 5/7 preterm, AGA discharge - 26 days Idiopathic *
cesarean male 2790 1/9/10 36 1/7 preterm, AGA death – 3 days Idiopathic *
cesarean female 3310 9/10/10 38 4/7 term,  AGA discharge - 8 days Idiopathic *
cesarean female 1550 0/6/7 34 5/7 preterm, AGA death - 2 days Idiopathic
cesarean female 3260 1/1/1 33 1/7 preterm, LGA death - 2 hours Idiopathic
cesarean female 1700 2/7/7 30 preterm, AGA death - 10 days Idiopathic + sepsis *
cesarean female 2920 2/7/8 35 5/7 preterm, AGA death - 10 days Idiopathic
* Antenatal diagnosis for nonimmune hydrops fetalis, AGA = adequate for gestational age, LGA = large for gestational age, Apgar-1st, 2nd and
5th minute of life.
Ramos’ intrauterine growth curve14,
using the 10th and 90th percentiles as
limits, was used to assess the nutri-
tional adequacy of the birth weight to
GA. The newborn with an inferior
birth weight (under the 10th percen-
tile), was classified as small for GA
(SGA), the newborn with birth weight
between the percentiles 10 and 90 was
considered adequate for GA (AGA),
and the ones with a birth weight higher
than the 90th percentile of the reference
curve were considered large for GA
(LGA).
An Apgar score of less than or equal
to 6 in the 5th minute of life character-
ized the presence of perinatal asphyxia.
Regarding the etiopathic diagno-
sis, the cases of NHF were classified in
the following categories: cardiovascu-
lar, infectious, genetic, hematological,
placental, miscellaneous and/or asso-
ciated causes, and idiopathic.
RESULTS
During the period of study, 11,190
live births occurred in the service. In
this population, the diagnosis of hy-
drops fetalis was made in 47 newborns
(0.42% of the live births); 18 (38.3%)
of whom presented an immune form
and 29 (61.7%) with a nonimmune
form, with an incidence of nonimmune
hydrops fetalis (NHF) of 1 per 414 live
births during this period. The data ob-
tained was derived from 21 newborns,
of whom 19 (90.5%) had been diag-
nosed prenatally (Table 2).
Regarding the characteristics of the
newborns (Table 3), 18 (85.7%) were de-
livered by cesarean, 15 (71.4%) were fe-
male, and 10 (47.6%) presented perina-
tal asphyxia. The average birth weight
was 2665.9 g ± 613 (1550 – 3600 g), and
the average GA was 35.5 weeks ± 2.4
(30 – 39 3/7 weeks), with 14 of these
(66.6%) being born preterm. Regarding
the nutritional classification, 18 (85.7%)
were adequate and 3 (14.3%) were large
for GA. The average length of hospital
stay was 26 ± 23.6 days, the mortality
rate was 52.4% (11 newborns), and the
age at death was 4.55 ± 4.2 days of life.
An etiopathic diagnosis was obtained
in 62% of the newborns; 19.0% of these
were cardiovascular, 9.5% infectious,
4.8% placental, 4.8% hematologic, 4.8%
genitourinary, 4.8% tumoral causes,
and in 9.5% there was a combination of
causes. The etiology was not identified
in 38% of the cases, which were classi-
fied as idiopathic NHF (Table 4).
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Table 4 - Data from the review of the literature regarding the etiopathic
classification of nonimmune hydrops fetalis.
Causes for POESCHAMANN et al# PROENÇA et al#
Nonimmune hydrops fetalis modified 21 cases
529 cases
Cardiovascular n=120 (23%) n=4 (19%)
· malformations 50 (42%) 2 (50%)
· arrhythmia 37 (31%) 1 (25%)
· other 33 (27%) 1 (25%)
Genetics n=70 (14%) n=2 (9.5%)
· trisomy 21 16 (23%) -
· Turner’s syndrome 18 (26%) -
· skeletal 20 (28%) 1 (50%)
· other 18 (25%) 1 (50%)
Infectious n=17 (3%) n=2 (9.5%)
· CMV 7 (41%) -
· toxoplasmosis 3 (18%) 1 (50%)
· other 7 (41%) 1 (50%)
Placental n=38 (7%) n=1 (4.76%)
· twin-twin transfusion syndrome 32 (84%) 1 (100%)
· other 6 (16%) -
Hematologic n=24(4.5%) n=1 (4.76%)
· alpha-thalassemia 12 (50%) 1 (100%)
· nonhemolytic anemia 11 (46%) -
· other 1 (4%) -
Miscellaneous n=107 (20.5%) n=3 (14.3%)
· respiratory 30 (28%) -
· gastrointestinal 26 (24%) -
· genitourinary 22 (21%) -
· other 30 (28%) 3 (100%)
Idiopathic n=150 (28%) n=8 (38%)
#Adapted from the work of Poeschamann et al.4, using literature data gathered by the author
between 1967-1987.
Table 3 - Characterization of the newborn infants with nonimmune hydrops fetalis.
n (21) % mean ± SD range
DELIVERY TYPE BIRTH WEIGHT
Vaginal 3 14.3 (g) 2.665.9 ± 613.0 1550 - 3600
Cesarean 18 85.7
GENDER GESTATIONAL AGE
Female 15 71.4 (weeks) 35.5 ± 2.4 30 – 39 3/7
Male 6 28.6
PERINATAL ASPHYXIA LENGTH OF
Yes 10 47.6 HOSPITAL STAY 26.6 ± 23.6 3 – 44
No 11 52.4 (days)
CLASSIFICATION AGE OF DEATH
adequate for gestational age 18 85.7 (days) 4.55 ± 4.2 1 - 12
large for gestational age 3 14.3
type until 1943, when Potter described
17 hydrops fetalis cases without asso-
ciated isoimmunization4. The most fre-
quently reported etiology of hydrops
fetalis until the 1960s was the
isoimmunization by the Rh factor1.
Nowadays, the prenatal treatment
of immune hydrops is so efficient that
in many situations it can revert the dis-
ease course through prophylaxis with
anti-D immunoglobulin and the
through intrauterine transfusion.
Therefore, NHF appears to be the most
important cause of perinatal hydrops
fetalis, being responsible for 75% of
the cases15. In this study, the immune
etiology occurred in 38% of the
newborns, which shows that these rates
in our environment still remain high,
probably because ours is a reference
service for hemolytic disease related to
the Rh system, as well as because of a
deficiency in prenatal monitoring of
those pregnancies at risk for develop-
ing immune hydrops.
The reported incidence of NHF is
relatively low compared with this
study, at approximately 1 per 3000
live births2. In this study, 1 case of
NHF was observed for every 414 live
births, a frequency 7.6 times higher
than in the general population. The
explanation of this fact is quite sim-
ple: since this medical center is a ter-
tiary and quaternary reference in the
DISCUSSION
The first report concerning hy-
drops fetalis was made by Diamond in
1932, who described a newborn with
erythroblastosis fetalis in a terminal
stage of generalized edema2. The im-
mune etiology was the only known
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health system for risk pregnancy, it
therefore selects for a larger number of
hydropic fetuses.
As previously mentioned, strict
control during the prenatal period of
pregnancies involving hydropic fe-
tuses and the precise indication of the
type of delivery required to improve
the fetal prognosis led to a high fre-
quency of cesarean deliveries (85.7%)
and prematurity (67%).
Prenatal diagnosis of NHF was ac-
complished in more than 90% of the
cases, and the etiology was determined
in 62%. The better prognosis and a
lower morbidity and mortality are re-
lated to these facts because follow-up
of the pregnancy in a specialized
center permits the creation of better
delivery conditions.
The analysis of the study popula-
tion showed that the average birth
weight was 2.665 ± 613 g, and regard-
ing the nutritional classification, 18
(85.6%) of the newborns were classi-
fied as adequate for GA, 3 (14.3%) as
large for GA, and none as small for GA.
The presence of fluids in the intersti-
tial space results in newborns with a
weight higher than expected for GA
because of the increase in the total
body fluid, therefore explaining the
higher frequency of adequate and
large newborns for GA.
This fact deserves to be emphasized
because it is very difficult to evaluate
nutritional status of hydropic
newborns. The anthropometric param-
eters (weight, length, head and arm cir-
cumference, and skinfold thickness)
widely used in the neonatal period
must be avoided in those children. Ad-
ditionally, biochemical parameters
such as the visceral protein determina-
tion do not apply either. The use of the
fetal growth curve (birth weight x GA)
will tend to result in classifications
that are at a higher level than the ac-
tual nutritional status, as previously
mentioned16,17.
Imaging methods, such as ultra-
sonography and sectional computer-
ized tomography of the arm, could
have some utility in the nutritional
evaluation, since they can be used to
estimate the mass. Nevertheless, these
methods are not yet well defined for
neonatals18.
Regarding perinatal asphyxia, the
frequency found in this population of
52% reinforces the hypothesis that the
presence of hydrops is a relevant fac-
tor in the worsening of the fetal wel-
fare because, in addition to the
unfavorable condition during the in-
trauterine life, the generalized edema
causes a more difficult delivery.
The predominance of females
(71.4%) occurring in our study is a find-
ing that is not reported in the literature,
because those studies did not focus on
gender differences in the incidence.
However, some of the etiologies of hy-
drops are more prevalent in females.
When we compared our etiopathic
diagnosis data with that in the literature
(Table 4), we found that the main causes
of NHF were variable in every studied
population. This variation is due to a
variety of factors; the two primary ones
are 1) the influence of genetics, where
an example is the higher frequency of
cases due to hematologic causes in
southeastern Asian populations where
there are higher numbers of alpha-
thalassemia carriers5,19; and 2) the vari-
ation in the occurrence of infectious
diseases, where an example is the in-
crease in the diagnosis of hydrops that
is secondary to infection by parvovirus
B195,20,21 in the last decade, due to a
real increase in the number of cases or
an improvement in the diagnosis of this
viral disease.
The primary cause of NHF in this
study arose from cardiovascular origin
(19%), which is comparable to other
studies in which cardiovascular dis-
eases appear in 15% to 27% of the hy-
dropic newborns, mainly due to ar-
rhythmia and structural defects9,23.
Genetic abnormalities, primarily
the chromosomopathies including tri-
somy 21 and 18 and Turner syn-
drome24,25, have been associated with
hydropic fetuses in which this
chromosomopathy can be the only
cause of edema or it can be associated
with other pathologies. In this study,
genetic causes were responsible for
9.5% of the cases, but when evaluated
for association with other causes, an
increase of the incidence to 19% was
observed. This increased incidence
probably occurs because of the com-
bination of the different pathophysi-
ologic mechanisms, causing a fetus
with a chromosomal abnormality
evolve to hydrops.
The percentage of the idiopathic
cases varies in the literature, depending
primarily on the diagnostic methods
available in each service. In this study,
the etiopathic diagnosis of NHF was not
achieved in 8 (38%) newborns.
The reported mortality rate for fetal
hydrops is very high, around 50% to
100%10, depending on the etiology22. In
this study, 11 (52.4%) evolved to death,
showing that the mortality rate, al-
though high, was lower than in other
major studies. Moreover, the deaths oc-
curred primarily in the first week of life
(average of 4.55 ± 4.2 days), arising out
of complications associated with
hypervolemia, such as cardiac, renal,
and respiratory insufficiencies.
It has been reported that just 20%
to 25% of the newborns with idi-
opathic NHF survive in the neonatal
period2. This study’s findings concur,
with survival of only 2 (25%) of the 8
newborns with idiopathic etiology.
This failure to survive is a conse-
quence of various factors, of which the
following stand out: the impossibility
of an adequate control, either prenatal
or postnatal, of the etiopathic cause
that resulted in the generalized edema;
a higher frequency of prematurity; and
increased severity of hydrops at birth,
increasing the difficulty of postnatal
treatment.
130
REV. HOSP. CLÍN. FAC. MED. S. PAULO 58(3):125-132, 2003Characterization of newborns with nonimmune hydrops fetalis
Mascaretti RS et al.
The newborns that survived re-
mained hospitalized for a long period
(average of 26.6 ± 23.6 days), either
because of the need for a prolonged
treatment or the need to control the
etiopathic causes and the secondary
complications of prematurity and hy-
drops.
In summary, when confronted with
the possibility of hydrops fetalis dur-
ing the gestation, all possible effort
should be made to achieve an
etiopathic diagnosis. First it must be
determined whether the hydrops are
immune or nonimmune so treatment
may be initiated. The establishment of
a correct etiopathic diagnosis associ-
ated with precocious nonimmune hy-
drops is fundamental to an adequate
selection of the prenatal and neonatal
therapeutic approach, reducing as a
consequence the morbidity and mor-
tality risks associated with this serious
dysfunction.
RESUMO
MASCARETTI RS e col. – Caracteri-
zação dos recém-nascidos com
hidropisia fetal não imune admiti-
dos em uma unidade neonatal de
terapia intensiva. Rev. Hosp. Clín.
Fac. Med. S. Paulo 58(3):125-132,
2003.
OBJETIVOS: Determinar a inci-
dência e caracterizar a população de
recém-nascidos com hidropisia fetal
não imune.
MÉTODO: Estudo retrospectivo,
referente ao período de 1996 a 2000,
incluindo todos os recém-nascidos
com diagnóstico antenatal ou neo-
natal, com base na história clínica,
exame físico e avaliação laboratorial.
Foram analisados: seguimento pré-na-
tal, tipo de parto, sexo, peso de nasci-
mento, idade gestacional, presença de
asfixia perinatal, classificação nutri-
cional, diagnóstico etiopatogênico,
tempo de internação, mortalidade, ida-
de do óbito.
RESULTADOS: Foram seleciona-
dos 47 recém-nascidos com hidropisia
fetal (0,42% dos nascidos vivos), 18
(38,3%) com a forma imune e
29(61,7%) com a não imune. A incidên-
cia de hidropisia fetal não imune foi de
1:414 nascidos vivos. Obtiveram-se da-
dos de 21 recém-nascidos destes, 19
(90,5%) apresentavam suspeita diag-
nostico antenatal, 18 (85,7%) nasceram
de parto cesariano; 15 (71,4%) eram do
sexo feminino; 10 (47,6%) foram asfi-
xiados. O peso médio foi 2665,9g, e a
idade gestacional média de 35 3/7 sem,
14 (66,6%) pré-termo; 18 (85,7%) ade-
quados e 3 (14,3%) grandes para idade
gestacional. O diagnóstico etiopa-
togênico foi realizado em 62% dos re-
cém-nascidos, sendo decorrente de cau-
sas cardiovasculares (19%), infecciosas
(9,5%), placentária (4,76%), hematoló-
gicas (4,76,%), gênito-urinária (4,76%),
tumoral (4,76%) e houve associação de
causas em 9,5%. A etiologia foi classi-
ficada em idiopática em 38%. O tempo
de internação foi de 26,6 dias ± 23,6 e
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a mortalidade de 52,4%.
CONCLUSÕES: O estabelecimen-
to de um correto diagnóstico etiopato-
gênico, associado à detecção antenatal
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da hidropisia fetal não imune, consti-
tui elemento importante para uma re-
dução da mortalidade neonatal decor-
rente desta grave doença.
DESCRITORES: Hidropisia fetal.
Hidropisia fetal não imune. Recém-
nascido. Anasarca. Hidrópico.
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